ReviewSubstance abuse : research and treatment2016
Improving Access to Long-Acting Contraceptive Methods and Reducing Unplanned Pregnancy Among Women with Substance Use Disorders.
Review in Substance abuse : research and treatment, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 56 citations in OpenAlex.
- Increasing access to family planning services among women receiving medications for opioid use disorder: A pilot randomized trial examining a peer-led navigation intervention.Journal of substance abuse treatment · 2021Trial
- Sex and female empowerment (SAFE): A randomized trial comparing sexual health interventions for women in treatment for opioid use disorder.Drug and alcohol dependence · 2021Trial
- Facilitating gynecological examination and long acting reversible contraception for women with substance use disorder: a prospective cohort study.BMC women's health · 2025Article
- Contraceptive uptake in postpartum people with and without opioid use disorder and opioid use with co-occurring substance use.Drug and alcohol dependence reports · 2024Article
- The co-creation and evaluation of a recovery community center bundled model to build recovery capital through the promotion of reproductive health and justice.Addiction research & theory · 2024Article
- Factors associated with unintended pregnancy and contraceptive practices in justice-involved adolescent girls in Australia.PloS one · 2024Article
- Sex and Female Empowerment (SAFE): Learning from health care providers, men and women to design a sexual health intervention for women with substance use disorders.Drug and alcohol dependence · 2023Article
- Barriers to and facilitators of hormonal and long-acting reversible contraception access and use in the US among reproductive-aged women who use opioids: A scoping review.Preventive medicine reports · 2023Article
- Contraception claims by medication for opioid use disorder prescription status among insured women with opioid use disorder, United States, 2018.Contraception · 2023Article
- Increasing access to immediate postpartum contraceptive implants: a prospective clinical trial among patients with opioid use disorder.The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception · 2022Article
- Association of Prepregnancy Substance Use and Substance Use Disorders with Pregnancy Timing and Intention.Journal of women's health (2002) · 2022Article
- A Comparison of Sex-Specific Reproductive and Sexual Health Needs between Addiction Medicine and Primary Care Treatment Settings.Substance use & misuse · 2022Article
- Ethical Issues in Providing and Promoting Contraception to Women with Opioid Use Disorder.The Journal of clinical ethics · 2022Article
- Perspectives among women receiving medications for opioid use disorder: Implications for development of a peer navigation intervention to improve access to family planning services.Substance abuse · 2022Article
- Long-acting reversible contraceptives (LARCs) as harm reduction: a qualitative study exploring views of women with histories of opioid misuse.Harm reduction journal · 2021Article
- Contraceptive use in Appalachian women who use drugs and were recruited from rural jails.Social work in health care · 2020Article
- Contraceptive Method Choices in Women With and Without Opioid Use Who Have Infants in the Neonatal Intensive Care Unit and Nursery.Women's health reports (New Rochelle, N.Y.) · 2020Article
- Claims for contraceptive services among young women filling chronic opioid prescriptions.Contraception · 2019Article
- Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach?BMC pregnancy and childbirth · 2018Review
- A Retrospective Chart Review of Contraceptive Use among Adolescents with Opioid Use Disorder.Journal of pediatric and adolescent gynecology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Much has been written about the consequences of substance use in pregnancy, but there has been far less focus on the prevention of unintended pregnancies in women with substance use disorders (SUDs). We examine the literature on pregnancy incidence for women with SUDs, the clinical and economic benefits of increasing access to long-acting reversible contraceptive (LARC) methods in this population, and the current hurdles to increased access and uptake. High rates of unintended pregnancies and poor physical and psychosocial outcomes among women with SUDs underscore the need for increased access to, and uptake of, LARC methods among these women. A small number of studies that focused on improving access to contraception, especially LARC, via integrated contraception services predominantly provided in drug treatment programs were identified. However, a number of barriers remain, highlighting that much more research is needed in this area.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.